Journal
BIOMATERIALS
Volume 30, Issue 31, Pages 6327-6332Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2009.08.005
Keywords
Magnetism; Nanoparticle; Microencapsulation; MRI (magnetic resonance imaging); Embolization
Funding
- Canada Research Chair program
- Canada Foundation for Innovation
- National Sciences and Engineering Research Council of Canada (NSERC)
- Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)
- Government of Quebec
Ask authors/readers for more resources
In this work, therapeutic magnetic micro carriers (TMMC) guided in real time by a magnetic resonance imaging (MRI) system are proposed as a mean to improve drug delivery to tumor sites. MRI steering constraints and physiological parameters for the chemoembolization of liver tumors were taken into account to design magnetic iron-cobalt nanoparticles encapsulated into biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles with the appropriate saturation magnetization (M-s). FeCo nanoparticles displayed a diameter of 182nm and an M-s of 209 emu g(-1). They were coated with a multilayered graphite shell to minimize the reduction of M-s during the encapsulation steps. FeCo-PLGA microparticles, with a mean diameter of 58 mu m and an M-s of 61 emu g(-1), were steered in a phantom mimicking the hepatic artery and its bifurcation, with a flow in the same order of magnitude as that of the hepatic artery flow. The steering efficiency, defined as the amount of FeCo-PLGA microparticles in the targeted bifurcation channel divided by the total amount of FeCo-PLGA microparticles injected, reached 86%. The data presented in this paper confirms the feasibility of the steering of these TMMC. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available